Rodec Pharma Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 1.04 M
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 68.48 Cr
- Satisfied Charges ₹ 8.51 Cr
About Rodec Pharma
Rodec Pharma Limited (RPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 November 1997 and has a history of 27 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Rodec Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 1.04 M.
The company currently has active open charges totaling ₹68.48 Cr. The company has closed loans amounting to ₹8.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Gupta, Chhaya Gupta, and Utkarsh Gupta serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233DL1997PLC090729
-
Company No.
090729
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 1997
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rodec Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Gupta
|
Director | 01-Dec-2000 | Current |
|
Chhaya Gupta
|
Director | 18-Nov-1997 | Current |
|
Utkarsh Gupta
|
Director | 24-Mar-2023 | Current |
Financial Performance of Rodec Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rodec Pharma?
Unlock access to Rodec Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rodec Healthcare Private LimitedMukesh Gupta and Chhaya Gupta are mutual person
-
M2g Health Solutions Private LimitedMukesh Gupta is a mutual person
Charges (Loans)
₹68.48 Cr
₹8.51 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 67.97 Cr
- Axis Bank Limited : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2024 | Hdfc Bank Limited | ₹3.00 M | Open |
| 22 Jun 2023 | Hdfc Bank Limited | ₹1.66 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 28 Jun 2022 | Hdfc Bank Limited | ₹66.50 Cr | Open |
| 19 Nov 2020 | Axis Bank Limited | ₹5.17 M | Open |
How Many Employees Work at Rodec Pharma?
Unlock and access historical data on people associated with Rodec Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rodec Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rodec Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
